Conference Reports for NATAP
21st Conference on Retroviruses and
Opportunistic Infections
Boston, MA March 3 - 6, 2014
Back
 
Tweet
A Multiple Dose Study of Raltegravir Formulations
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
M.L. Rizk, R. Krishna, V. Schulz, J. ten Bruggencate-Broeders, P. Larson, L. Wenning
Merck & Co., Inc., Whitehouse Station, NJ